About livanova plc - LIVN
LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). The Cardiopulmonary segment is involved in the design, development, manufacture, marketing and selling of cardiopulmonary products. The Neuromodulation segment is associated in the design, development, manufacture, marketing and selling of devices that deliver neuromodulation therapy for treating DRE and DTD. The ACS segment deals with the design, development, manufacture, marketing and selling of temporary life support products. The company was founded in 1987 and is headquartered in London, the United Kingdom.
LIVN At a Glance
LivaNova Plc
20 Eastbourne Terrace
London, Greater London W2 6LG
| Phone | 44-203-325-0660 | Revenue | 1.39B | |
| Industry | Medical Specialties | Net Income | -242,471,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 10.74% | |
| Fiscal Year-end | 12 / 2026 | Employees | 3,300 | |
| View SEC Filings |
LIVN Valuation
| P/E Current | 38.055 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 2.418 |
| Price to Book Ratio | 2.802 |
| Price to Cash Flow Ratio | 13.20 |
| Enterprise Value to EBITDA | 11.078 |
| Enterprise Value to Sales | 2.273 |
| Total Debt to Enterprise Value | 0.138 |
LIVN Efficiency
| Revenue/Employee | 420,622.121 |
| Income Per Employee | -73,476.061 |
| Receivables Turnover | 6.427 |
| Total Asset Turnover | 0.543 |
LIVN Liquidity
| Current Ratio | 1.363 |
| Quick Ratio | 1.159 |
| Cash Ratio | 0.787 |
LIVN Profitability
| Gross Margin | 68.014 |
| Operating Margin | 16.219 |
| Pretax Margin | -15.906 |
| Net Margin | -17.468 |
| Return on Assets | -9.486 |
| Return on Equity | -19.242 |
| Return on Total Capital | -14.841 |
| Return on Invested Capital | -13.842 |
LIVN Capital Structure
| Total Debt to Total Equity | 36.148 |
| Total Debt to Total Capital | 26.551 |
| Total Debt to Total Assets | 16.645 |
| Long-Term Debt to Equity | 32.793 |
| Long-Term Debt to Total Capital | 24.086 |